Related and Nonrelated Parties [Axis] Related Party [Member] Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Award Type [Axis] Stock Options [Member] Common Stock Warrants [Member] Legal Entity [Axis] Miralogxllc [Member] Project [Axis] License Agreement [Member] Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Class of Stock [Axis] Common Stock Purchase Warrant [Member] Statistical Measurement [Axis] Minimum [Member] Asset Acquisition [Axis] Telomir Pharmaceuticals Inc [Member] SKNY Pharmaceuticals Inc [Member] Investment, Name [Axis] Undesignated Preferred Stock [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] ATM Agreement [Member] Restricted Stock Units (RSUs) [Member] Plan Name [Axis] 2022 Omnibus Plan [Member] Maximum [Member] Title and Position [Axis] Director [Member] Share-Based Payment Arrangement, Option [Member] Warrant [Member] Segments [Axis] Single Reportable Segment [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Defined Benefit Plan [Table] Defined Benefit Plan Disclosure [Line Items] ASSETS Current assets: Cash Prepaid expenses Short-term investments – related party Total current assets Related party receivable Total assets LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Trade accounts payable and accrued liabilities Accrued compensation – related party Advance payable to related party Total current liabilities Total liabilities Commitments and contingencies (Note 6) Stockholders’ Equity Preferred Stock, $0.0001 par value, 10,000,000 shares authorized and none issued or outstanding. Common Stock, $0.0001 par value; 100,000,000 shares authorized, 42,022,087 and 41,938,587 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively. Additional paid-in capital Accumulated deficit Total stockholders’ equity Total liabilities and stockholders’ equity Statement of Financial Position [Abstract] Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenues Operating costs: General and administrative expenses Research and development expenses Total operating costs Other (expense) income: Interest income Other expense Loss from equity method investment – related party Total other (expense) income, net Net Loss Basic loss per share Diluted loss per share Basic weighted average common stock shares outstanding Statement [Table] Statement [Line Items] Balance Balance, shares Stock-based compensation Shares issued for vested RSUs Shares issued for vested RSUs, shares Net loss Issuance of common stock under ATM, net of costs Issuance of common stock under ATM, net of costs, shares Balance Balance, shares Statement of Cash Flows [Abstract] Cash flows from operating activities Adjustments to reconcile net loss to net cash used in operations Stock-based compensation expense Loss from equity method investment Change in operating assets and liabilities: Prepaid expenses Trade accounts payable and accrued expenses Accrued compensation – related party Net cash used in operating activities Financing activities: Repayment of advance payable to related party Offering costs Proceeds from ATM equity offering Net cash (used) provided by financing activities Net decrease in cash Cash, beginning of period Cash, end of period Supplemental disclosure of cash flow information Cash paid for interest Cash paid for taxes Accounting Policies [Abstract] Description of business and summary of significant accounting policies Prepaid Expenses Prepaid expenses License Agreement Related Party License agreement, related party Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract] Asset acquisition and short-term investment – related party Related Party Transactions [Abstract] Related party transactions Commitments and Contingencies Disclosure [Abstract] Commitments and contingencies Equity [Abstract] Stockholders’ equity Segment Reporting [Abstract] Segment information Subsequent Events [Abstract] Subsequent Events Overview Basis of Presentation and Principles of Consolidation Reclassifications Use of estimates Certain Risks and Uncertainties Cash Investments in Equity Securities, Equity Method Investments Fair Value of Financial Instruments Revenue Recognition Research and Development Expenses General and Administrative Expenses Stock-Based Compensation Income Taxes Operating Segments Leases Contingencies Warrants Loss per Share Recent Accounting Pronouncements Schedule of diluted net loss per share attributed to common stock Schedule of prepaid expenses Schedule of consolidated financial statements Schedule of option activity Schedule of restriscted stock unit activity Schedule of warrant activity Segment Reporting [Table] Segment Reporting [Line Items] Schedule of segment expenses and other segment expenses Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Totals Cash Net cash provided by used in operating activities Net income loss Stockholders equity Accrued compensation related party Cash, FDIC Insured Amount Cash, Uninsured Amount Schedule Of Prepaid Expenses Prepaid expense: Prepaid insurance Other prepaid expense Total prepaid expenses LicenseAgreementRelatedPartyTable [Table] Non refundable payments Issuance of common stock shares Warrants exercise price Obligated to pay a royalty payment percentage Royalty expense Current assets Noncurrent assets Current liabilities Noncurrent liabilities Net revenue Net loss Asset Acquisition [Table] Asset Acquisition [Line Items] Issuance of acquisition Issuance of acquisition Share price Issuance of common share Equity method investment ownership percentage Equity method loss Short term investments Related Party Transaction [Table] Related Party Transaction [Line Items] Accounts receivable related party Number of shares, outstanding beginning balance Weighted-Average Exercise Price, Outstanding, Beginning Weighted- Average Remaining Contractual Term Aggregate Intrinsic Value, Outstanding, Beginning Number of shares, options granted Weighted-Average Exercise Price, Granted Number of shares, forfeitures and expired Weighted-Average Exercise Price, Forfeitures and Expired Number of shares, exercised Weighted-Average Exercise Price, Exercised Aggregate Intrinsic Value, Granted Number of shares, outstanding ending balance Weighted-Average Exercise Price, Outstanding, Ending Aggregate Intrinsic Value, Outstanding, Ending Number of shares, vested and exercisable Weighted-Average Exercise Price, Vested and Exercisable Weighted- Average Remaining Contractual Term, Exercisable Aggregate Intrinsic Value, Exercisable Number of restricted shares, unvested beginning balance Number of restricted shares, granted Number of restricted shares, expired and forfeitures Number of restricted shares, vested Number of restricted shares, unvested ending balance Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Number of Warrants, Outstanding, Balance Weighted-Average Exercise Price, Outstanding, Beginning Weighted-Average Remaining Contractual Term, Outstanding Aggregate Intrinsic Value, Outstanding, Beginning Number of Warrants, Granted Number of Warrants, Exercised Number of Warrants, Outstanding, Balance Weighted-Average Exercise Price, Outstanding, Ending Aggregate Intrinsic Value, Outstanding, Ending Number of Warrants, Exercisable Weighted-Average Exercise Price, Exercisable Weighted-Average Remaining Contractual Term, Exercisable Aggregate Intrinsic Value, Exercisable Stock, Class of Stock [Table] Class of Stock [Line Items] Capital stock, shares authorized Undesignated preferred stock, shares authorized Proceeds from issuance of common stock Stock price Issuance of common stock value Commissions and other fees Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Restricted stock units, vested Number of restricted stock units issued, value Number of restricted shares, Unvested beginning balance Aggregate fair value of options Restricted stock vested percentage Common stock issued Reserved issuance shares Outstanding shares percentage Reserved issuance shares available for issuance Stock option Description of share-based payment Exercise price Risk-free interest rate Expected price volatility Dividend yield Expected term Share based compensation Unrecognized compensation costs Option expiration period Aggregate fair market value Other income (expense): Loss from equity method investments Total other income (expense), net Reportable segment Subsequent Event [Table] Subsequent Event [Line Items] Percentage of vesting Vesting Period Accrued compensation related party. Advance payable to related party. Unrealized gain loss on investment. Payment of deferred offering costs. Description Of Business [Policy Text Block] Reclassifications [Policy Text Block] Warrant [Policy Text Block] Disclosure Of Prepaid Expenses [Text Block] Schedule Of Prepaid Expenses [Table Text Block] License Agreement Related Party [Text Block] Miralogxllc [Member] License Agreement [Member] Common Stock Purchase Warrant [Member] Obligated to pay royalty payment percentage. Telomir Pharmaceuticals Inc [Member] SKNY Pharmaceuticals Inc [Member] Undesignated Preferred Stock [Member] ATM Agreement [Member] Outstanding shares percentage. 2022 Omnibus Plan [Member] Share based compensation arrangement by share based payment award equity instruments other than options expired and forfeited in period. Non Option Equity Instruments Exercisable Number. Non Options Exercisable Weighted Average Exercise Price. Share based compensation arrangement by share based payment award equity instruments non options outstanding weighted average remaining contractual terms. Share based compensation arrangement by share based payment award equity instruments non options exercisable weighted average remaining contractual terms. Share based compensation arrangement by share based payment award equity instruments non option aggregate intrinsic value outstanding. Share based compensation arrangement by share based payment award equity instruments non options aggregate intrinsic value. Restricted stock vested percentage. Stock Options [Member] Common Stock Warrants [Member] Reserved issuance shares available for issuance. Single Reportable Segment [Member] Assets, Current Assets Liabilities, Current Liabilities Liabilities and Equity Operating Expenses Other Nonoperating Expense Other Nonoperating Income (Expense) Shares, Outstanding Increase (Decrease) in Prepaid Expense Increase (Decrease) in Deferred Compensation Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Repayments of Related Party Debt PaymentOfDeferredOfferingCosts Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation DisclosureOfPrepaidExpensesTextBlock Cash and Cash Equivalents, Policy [Policy Text Block] Cash [Default Label] Business Combination, Separately Recognized Transactions, Net Gains and Losses Stock Issued During Period, Value, Acquisitions Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionAggregateIntrinsicValueOutstanding ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsAggregateIntrinsicValue Nonoperating Income (Expense)